BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1779460)

  • 1. [Intermittent administration of natural interferon-alpha for over 5 years induced complete suppression of Philadelphia chromosome in a patient with myelogenous leukemia].
    Koyama S; Aoki S; Furukawa T; Takahashi M; Kishi K; Koike T; Moriyama Y; Hattori A; Shibata A
    Rinsho Ketsueki; 1991 Dec; 32(12):1577-9. PubMed ID: 1779460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Natural interferon-alpha induced cytogenetic complete remission in a patient with chronic myelocytic leukemia, diagnosed in early chronic phase with basophilia and normal blood cell counts].
    Koyama S; Moriyama Y; Aoki A; Furukawa T; Narita M; Wada K; Kishi K; Takahashi M; Koike T; Shibata A
    Rinsho Ketsueki; 1992 Feb; 33(2):227-31. PubMed ID: 1635174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [One-year remission of chronic myelogenous leukemia (CML) after discontinuation of interferon-alpha].
    Kobayashi Y; Kimura S; Tanaka K; Kimura S; Wada K; Ozawa M; Maruo N; Kondo M
    Rinsho Ketsueki; 1990 Jul; 31(7):1013-6. PubMed ID: 2214181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hematologic response to low dose natural interferon-alpha in a case of CML with myelo-megakaryoblastic crisis].
    Nozaki H; Usui T; Yamauchi K; Kobayashi N; Nakamura Y; Watanabe K; Nagao T; Arimori S
    Rinsho Ketsueki; 1993 Feb; 34(2):232-4. PubMed ID: 8492424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Initial treatment of chronic myelogenous leukemia--interferon or bone marrow transplantation].
    Urabe A
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1381-6. PubMed ID: 10500523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular implication of Ph positive leukemias: treatment with alpha-interferon in Ph positive acute leukemia].
    Ohyashiki JH; Kawakubo K; Ohyashiki K; Toyama K
    Rinsho Byori; 1993 Dec; 41(12):1305-9. PubMed ID: 8295339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disappearance of Philadelphia chromosomes after remission induction in lymphoid crisis of chronic myelogenous leukemia].
    Nagafuji K; Iwakiri R; Miyamoto T; Okamura H; Yokota E; Matsumoto I
    Rinsho Ketsueki; 1992 Sep; 33(9):1226-30. PubMed ID: 1433945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.
    Kantarjian HM; O'Brien S; Cortes J; Giles FJ; Rios MB; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Verstovsek S; Wierda W; Keating M; Talpaz M
    Cancer; 2003 Dec; 98(12):2636-42. PubMed ID: 14669283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complete cytogenetic response to interferon-alpha in a patient with chronic myelogenous leukemia undergoing hemodialysis].
    Doi S; Edamura S; Akasaka H; Kawamura M; Arima N; Nasu K
    Rinsho Ketsueki; 2001 Jul; 42(7):549-53. PubMed ID: 11524845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [RAEB transformed into AML (M0) showing Ph1 chromosome and rearrangement of major cluster region].
    Mori H; Takahashi N; Tada J; Higuchi T; Shimizu T; Harada H; Maeda T; Miyoshi Y; Okada S; Niikura H
    Rinsho Ketsueki; 1993 Nov; 34(11):1458-63. PubMed ID: 8254908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
    O'Brien S; Giles F; Talpaz M; Cortes J; Rios MB; Shan J; Thomas D; Andreeff M; Kornblau S; Faderl S; Garcia-Manero G; White K; Mallard S; Freireich E; Kantarjian HM
    Cancer; 2003 Sep; 98(5):888-93. PubMed ID: 12942553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea].
    Motomura S; Sakai R; Tomita N; Fujimaki K; Hattori M; Fujisawa S; Mohri H; Takahashi N; Maruta A; Kodama F; Okubo T
    Rinsho Ketsueki; 1998 Apr; 39(4):302-7. PubMed ID: 9597898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Triploid clone observed at blastic crisis in chronic myelogenous leukemia with complex Ph1 translocation (9; 22; 12)].
    Ito K; Murakami S; Oku N; Takeda N; Shimazaki C; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Fujita N
    Rinsho Ketsueki; 1989 Apr; 30(4):558-62. PubMed ID: 2769978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic myelocytic leukemia induced into remission by interferon-alpha associated with early esophageal cancer].
    Annoh S; Umeda M; Arai N; Shikoshi K; Su CY; Yasushi T; Kitazawa Y; Shirai T
    Rinsho Ketsueki; 1991 Jul; 32(7):786-90. PubMed ID: 1920843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interferon treatment in chronic myeloid leukemia].
    Simonsson B
    Nord Med; 1992; 107(3):76-7, 79. PubMed ID: 1549456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
    Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Natural interferon alpha for chronic myelogenous leukemia in the chronic phase: hematologic, cytogenetic and molecular response].
    Takeuchi J; Kawamura M; Sawada U; Ohshima T; Horie T; Horikoshi A; Abe T
    Rinsho Ketsueki; 1995 Oct; 36(10):1149-56. PubMed ID: 8531323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome].
    Meng FY; Sun J; Liu QF; Xu D; Yang LJ; Song LL; Liu XL; Xu B; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1301-2, 1306. PubMed ID: 14678896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.